{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:26:37Z","timestamp":1761899197031,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.cancergen.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T19:44:24Z","timestamp":1679341464000},"page":"30-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Detection of an atypical BCR::ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia\/lymphoma following multiple myeloma treatment"],"prefix":"10.1016","volume":"274-275","author":[{"given":"Karin","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3647-6345","authenticated-orcid":false,"given":"Jonathan","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8563-195X","authenticated-orcid":false,"given":"Philip","family":"Imus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"Ament","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-1917","authenticated-orcid":false,"given":"Ying S.","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.cancergen.2023.03.005_bib0001","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)","volume":"118","author":"Mailankody","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cancergen.2023.03.005_bib0002","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41375-018-0213-y","article-title":"Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma","volume":"33","author":"Aldoss","year":"2019","journal-title":"Leukemia"},{"issue":"6020","key":"10.1016\/j.cancergen.2023.03.005_bib0003","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cancergen.2023.03.005_bib0004","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ajh.24926","article-title":"Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults","volume":"93","author":"El Fakih","year":"2018","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.cancergen.2023.03.005_bib0005","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.jmoldx.2021.07.015","article-title":"Diagnostic utility of gene fusion panel to detect gene fusions in fresh and formalin-fixed, paraffin-embedded cancer specimens","volume":"23","author":"Haley","year":"2021","journal-title":"J Mol Diagn"},{"issue":"4","key":"10.1016\/j.cancergen.2023.03.005_bib0006","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jmoldx.2021.01.011","article-title":"Clinical utility of targeted next-generation sequencing assay to detect copy number variants associated with myelodysplastic syndrome in myeloid malignancies","volume":"23","author":"Jiang","year":"2021","journal-title":"J Mol Diagn"},{"issue":"12","key":"10.1016\/j.cancergen.2023.03.005_bib0007","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1038\/bcj.2016.114","article-title":"Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial","volume":"6","author":"Jones","year":"2016","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.cancergen.2023.03.005_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cam4.799","article-title":"Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed\/refractory multiple myeloma patients","volume":"6","author":"Kotchetkov","year":"2017","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.cancergen.2023.03.005_bib0009","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/bmt.2015.8","article-title":"Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome","volume":"50","author":"Aldoss","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.cancergen.2023.03.005_bib0010","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3324\/haematol.2011.057752","article-title":"Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?","volume":"97","author":"Tang","year":"2012","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.cancergen.2023.03.005_bib0011","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF03256245","article-title":"Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias","volume":"11","author":"Bao","year":"2007","journal-title":"Mol Diagn Ther"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776223000182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776223000182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:46:33Z","timestamp":1761896793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776223000182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":11,"alternative-id":["S2210776223000182"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2023.03.005","relation":{},"ISSN":["2210-7762"],"issn-type":[{"type":"print","value":"2210-7762"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of an atypical BCR::ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia\/lymphoma following multiple myeloma treatment","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}